Generic Injectables Market PPT 2020: Global Industry Trends, Share, Size, Growth and Forecast 2025

Global Generic Injectables Market Research Report and Forecast 2025 Report Edition: 2020 © 2020 IMARC All Rights Reserved

Copyright © IMARC Service Pvt Ltd. All Rights Reserved

About IMARC Group

Report Description

The International Market Analysis Research and Consulting Group is a leading adviser on management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, chemicals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and markets with close cooperation at all levels of the client organization. This ensures that our clients achieve unmatchable competitive advantage, build more proficient organizations, and secure lasting results.

Report Description and Highlights

Report Description

Global Generic Injectables Market Overview: The latest report by IMARC Group, titled “ Generic Injectables Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 202 0-2025 ,� finds that the global generic injectables market size reached US$ 31.7 Billion in 2019. Generic injectables yield the same therapeutic effects as their innovator counterparts since they have similar active ingredients, strength, quality, performance, intended use and dosage. They allow the transportation of drugs directly into the body, in the liquid form, thereby reducing the frequency of dosage administration, without compromising on the effectiveness of the treatment. A high degree of quality and care in the manufacturing, packaging, storage and distribution of injectables is obligatory as they can be toxic and are vulnerable to contamination. Generic injectables are more effective than their oral counterparts and are preferred when the patients are unable to take medicines by mouth or have poor intestinal absorption.

Request for a free sample report: https://www.imarcgroup.com/generic-injectables-market/requestsample Global Generic Injectables Market Trends: The production of generic injectables is time- and cost-efficient as they do not require extensive

Report Description and Highlights

157.3 146.7 152.0 141.4 136.1 125.5 130.8

160 140 120 100 80 60 40 20 0

120.2 2012

2013

2014

2015

2016

2017

2018

2019

In Billion US$

In Billion US$

Report Description

180 160 140 120 100 80 60 40 20 0

160.0 2020

175.9

181.2

186.5

165.3

170.6

2021

2022

2023

2024

2025

marketing, testing and research due to the established safety and efficacy profile of their branded counterparts. The governments of various countries are also supporting the manufacturing of generic injectables as they help in reducing the overall costs for patients, as well as healthcare providers. Apart from this, the rising prevalence of various chronic diseases, such as diabetes, cardiovascular disorders and Alzheimer’s disease, has increased the sales of generic injectables. They help in maximizing patient compliance without compromising the effectiveness of the treatment.

Report Description and Highlights

Report Description

Moreover, the leading generic drug companies are bolstering research and development (R&D) activities, engaging in acquisitions, or building their capabilities to develop complex and differentiated products. For instance, Mylan Inc. acquired the Agila injectables business from Strides Arcolab Limited to expand and strengthen its existing injectables portfolio. Some of the other factors fueling the growth of the market are the growing geriatric population, increasing drug shortages and rising patent expiry of several drugs. Looking forward, the market value is projected to reach US$ 53.7 Billion by 2025, growing at a CAGR of 9.2% over the forecast period.

For more information, click here: https://www.imarcgroup.com/generic-injectables-market Generic Injectables Market Segmentation: Market Segmentation by Therapeutic Area • • • • •

Oncology Anaesthesia Anti-infectives Parenteral Nutrition Cardiovascular

Report Description and Highlights

Report Description

Based on the therapeutic area, the market has been segmented into oncology, anesthesia, antiinfectives, parenteral nutrition and cardiovascular. Oncology currently represents the largest therapeutic area, accounting for the majority of the global market share.

Market Segmentation by Distribution Channel • •

Hospitals Retail Pharmacy

The market has been categorized based on the distribution channel into hospitals and retail pharmacies. At present, generic injectables are majorly distributed through hospitals.

Market Segmentation by Region • • • • •

Asia Pacific Europe North America Middle East and Africa Latin America

Report Description and Highlights

Report Description

Region-wise, North America holds the leading position in the market. Other major regions include Asia Pacific, Europe, Middle East and Africa, and Latin America.

Market Segmentation by Container • • • •

Vials Ampoules Premix Prefilled Syringes

On the basis of the container, vials are the most preferred container for generic injectables, followed by ampoules, premix and prefilled syringes.

Competitive Landscape: The competitive landscape of the market has also been examined with some of the key players.

•

Hospira (Pfizer Inc.)

Report Description and Highlights

Report Description • • • • •

Fresenius Kabi Ag Hikma Pharmaceuticals PLC Sandoz (Novartis) Sagent Pharmaceuticals, Inc. (Nichi-Iko Pharmaceutical Co. Ltd.) Sanofi

A partial List of

We are the trusted business partners to the

Clients world's leading corporates, governments, and ourPartial ClientsList of institutions

A partial List of

We are the trusted business partners to the

of Clients leading corporates, governments, and ourPartial ClientsListworld's institutions

Report Description and Highlights

Report Description

Š 2019 IMARC All Rights Reserved This Publication and all it’s contents unless otherwise mentioned are copyrighted in the name of International Market Analysis Research and Consulting (IMARC). No part of this publication may be reproduced, repackaged, redistributed or resold in whole or in any part. The publication may also not be used in any form or by and means graphic electronic or mechanical, including photocopying, recording, taping or by information storage or retrieval, or by any other form, without the express consent of International Market Analysis Research and Consulting (IMARC).

Disclaimer: All contents and data of this publication, including forecasts, data analysis and opinion have been based on information and sources believed to be accurate and reliable at the time of publishing. International Market Analysis Research and Consulting makes no representation of warranty of any kind as to the accuracy or completeness of any Information provided. IMARC accepts no liability whatsoever for any loss or damage resulting from opinion, errors or inaccuracies if any found this publication.

IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of International Market Analysis Research and Consulting. All other trademarks used in this publication are registered trademarks of their respective companies.

Contact Us

FOR MORE DETAILS Visit us at :

https://www.imarcgroup.com Stay With Us:

TELEPHONE: +1-631-791-1145 E-MAIL: sales@imarcgroup.com